Grufity logo
Grufity logo
RMED

RMED - Ra Medical Systems, Inc. Stock Price, Fair Value and News

Market Closed

Price Targets

RMED Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RMED Price Action

RMED RSI Chart

RMED Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RMED Valuation

Market Cap

1.7M

Price/Earnings (Trailing)

-0.11

Price/Sales (Trailing)

1.53

EV/EBITDA

-0.3

Price/Free Cashflow

-0.19

RMED Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

RMED Fundamentals

RMED Revenue

Revenue (TTM)

1.1M

Rev. Growth (Yr)

202.1%

Rev. Growth (Qtr)

81.51%

RMED Earnings

Earnings (TTM)

-15.0M

Earnings Growth (Yr)

58.44%

Earnings Growth (Qtr)

70%

RMED Profitability

Operating Margin

96.57%

EBT Margin

-1498.29%

Return on Equity

-163.74%

Return on Assets

-42.73%

Free Cashflow Yield

-515.86%

RMED Investor Care

Buy Backs (1Y)

70.95%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
20261.1M---
2025481.0K600.0K730.0K819.0K
2024439.0K436.0K399.0K420.0K
202390.0K181.0K314.0K442.0K
202228.0K24.0K19.0K14.0K
20211.8M1.2M602.0K22.0K
20201.5M1.8M2.1M2.3M
20197.0M8.0M7.8M1.3M
20186.0M6.1M6.2M6.3M
2017---5.9M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Ra Medical Systems, Inc.

RMED

Ra Medical Systems, Inc. Frequently Asked Questions

RMED is the stock ticker symbol of Ra Medical Systems, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Mar 31 2026, market cap of Ra Medical Systems, Inc. is 1.7 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Tue Mar 31 2026, RMED's PE ratio (Price to Earnings) is -0.11 and Price to Sales (PS) ratio is 1.53. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RMED PE ratio will change depending on the future growth rate expectations of investors.